Induced experiments for module 448

Experiment nameClinical attributes
Alizadeh00_Thymic_T_cells_Fetal_CD4_I_P_StimulatedLymphocytes (B lymphoma*), Primary blood mononuclear cells (B lymphoma), Normal lymphocytes (B lymphoma), T cells (B lymphoma)
Alizadeh00_Tonsil_Memory_B_lc4b050Lymphocytes (B lymphoma*), Normal lymphocytes (B lymphoma), B cells (B lymphoma*), Memory B cells (B lymphoma)
Boldrick02_Diversity_Dataset_S_aureus1_timecourse_0_0_hrLymphocytes (Stimulated PBMC*), Monocytes (Stimulated PBMC*), Primary blood mononuclear cells (Stimulated PBMC*), Hematologic samples (Stimulated PBMC*), Hematologic samples and cell lines (Stimulated PBMC*), Unstimulated immune cells (Stimulated PBMC)
Boldrick02_Dose_Response_Dataset_Bp338_1000X_dose_timecourse_0_5hrB. petrussis stimulated immune cells (Stimulated PBMC), Gram negative bacteria stimulated immune cells (Stimulated PBMC), B. petrussis 338 stimulated immune cells (Stimulated PBMC), Lymphocytes (Stimulated PBMC*), Monocytes (Stimulated PBMC*), Primary blood mononuclear cells (Stimulated PBMC*), Stimulated immune cells (Stimulated PBMC*), Hematologic samples (Stimulated PBMC*), Hematologic samples and cell lines (Stimulated PBMC*), 0.5hr immune stimulation (Stimulated PBMC), 1000X dose immune stimulation (Stimulated PBMC)
Boldrick02_Live_vs_Killed_Dataset_Bp338_Live_timecourse_4hrLive bacteria stimulated immune cells (Stimulated PBMC), B. petrussis stimulated immune cells (Stimulated PBMC), Gram negative bacteria stimulated immune cells (Stimulated PBMC), B. petrussis 338 stimulated immune cells (Stimulated PBMC), Lymphocytes (Stimulated PBMC*), Monocytes (Stimulated PBMC*), Primary blood mononuclear cells (Stimulated PBMC*), Stimulated immune cells (Stimulated PBMC*), Hematologic samples (Stimulated PBMC*), Hematologic samples and cell lines (Stimulated PBMC*)
Garber01_222_97_AdenoStage T2 (Lung cancer), Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Adenocarcinoma (Lung cancer), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*)
Perou00_BC107A_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Perou00_BC114B_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Perou00_BC305B_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Ramaswamy01_Tumor__Ovary_Adeno_0001c086Female hormonal tissue or cancer (Various tumors), Cancer (Various tumors), Adenocarcinoma (Various tumors), Cancer and cell line (Various tumors), Female hormonal tissue, cancer or cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*)
Ramaswamy01_Tumor__Ovary_Adeno_H_ 400 6346Female hormonal tissue or cancer (Various tumors), Cancer (Various tumors), Adenocarcinoma (Various tumors), Cancer and cell line (Various tumors), Female hormonal tissue, cancer or cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*)
Sorlie01_BC112B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer)
Sorlie01_BC11_FABreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Fibroadenoma (Breast cancer)
Sorlie01_BC18Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer)
Sorlie01_BC309A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC4_LN4Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer)